Britain approves Pfizer’s antiviral Covid-19 pill Paxlovid

Published by
DPA

Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) said on Friday that it has approved Pfizer’s Oral Covid-19 antiviral medicine, Paxlovid, for people with mild to moderate Covid-19 who are at high risk of developing severe cases. Paxlovid is an antiviral medicine with a combination of active ingredients, PF-07321332 and Ritonavir that works by inhibiting a protease required for virus replication. The drug has been authorized for use in people aged 18 and older who have mild to moderate Covid-19 infections and at least one risk factor for developing severe illness. Such risk …

Read More

Leave a Reply